Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of ethiopian AIDS patients

AIDS Research and Human Retroviruses

Volumn 15, Issue 7, 1999, Pages 647-653

  Björndal, Asa ^a   Sönnerborg, Anders ^b   Tscherning, Charlotte ^a   Albert, Jan ^c   Fenyö, Eva Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ETHIOPIA; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TYPING;

EID: 2442765375     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310944     Document Type: Article

References (32)

1. Myers G, Foley B, Mellors JW, Korber B, Jeang K-T, and Wain-Hobson S (eds.): Human Retroviruses and AIDS 1996. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 1996.
2. Marquina S, Leitner T, Rabinovich RD, Benetucci J, Libonatti O, and Albert J: Coexistence of subtypes B, F, and B/F env recombinant of HIV type 1 in Buenos Aires, Argentina. AIDS Res Hum Retroviruses 1996;12(17):1651-1654.
3. Björndal Å, Deng HK, Jansson M, Fiore JR, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman DR, and Fenyö EM: Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997;71(10): 7478-7487.
4. Scarlatti G, Tresoldi E, Björndal Å, Fredriksson R, Colognesi C, Deng HK, Malnati M, Plebani A, Siccardi AG, Littman DR, Fenyö EM, and Lusso P: Evolution of viral coreceptor usage and sensitivity to chemokines during the progression of the disease in children infected with HIV-1. Nature Med 1997;3: 1259-1265.
5. Rübsamen-Waigmann H, von Briesen H, Holmes H, Björndal Å, Korber B, Esser R, et al.: Standard conditions of virus isolation reveal biological variability of HIV-1 in different regions of the world. AIDS Res Hum Retroviruses 1994;10:1401-1408.
6. Ichimura H, Kliks SC, Visrutaratna S, Ou CY, Kalilsh ML, and Levy JA: Biological, serological and genetic characterization of HIV-1 subtype E isolates from northern Thailand. AIDS Res Hum Retroviruses 1994;10:263-269.
7. Holm-Hansen C, Grothues D, Rustad S, Rosok B, Pascu R, and Åsjö B: Characterization of HIV type 1 from Romanian children: Lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. AIDS Res Hum Retroviruses 1995;11(5):597-603.
8. Zhang L, Huang Y, He T, Chao Y, and Ho DD: HIV-1 subtype and second-receptor use. Nature (London) 1996;383:768.
9. Tscherning C, Alaeus A, Fredriksson F, Björndal Å, Deng HK, Littman DR, Fenyö EM, and Albert J: Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-188.
10. Ayehunie S, Sönnerborg A, Zewdie D, Britton S, and Strannegård Ö: Relationship between cell-free viremia, antigenemia and antibody levels in HIV-1 infected Ethiopian patients. AIDS 1992;6: 651-657.
11. Sherefa K, Sällberg M, and Sönnerborg A: Evidence of no change in V3 loop antibody recognition pattern in HIV type 1 infected Ethiopians between 1988 and 1993. AIDS Res Hum Retroviruses 1994;10:1547-1552.
12. Sherefa K, Johansson B, Sällberg M, Salminen M, and Sönnerborg A: Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable (V3) domain of gp120: Results may be affected by divergent V3 sequences. J Clin Microbiol 1997;35:2419-2421.
13. World Health Organization: Acquired immunodeficiency syndrome (AIDS). WHO/CDC case definition for AIDS. Wkly Epidemiol Rec 1986;61:69-73.
14. Ehrnst A, Sönnerborg A, Bergdahl S, and Strannegård Ö: Efficient isolation of HIV from plasma during different stages of HIV infection. J Med Virol 1988;26:23-32.
15. Åsjö B, Albert J, Chiodi F, and Fenyö EM: Improved tissue culture technique for production of poorly replicating human immunodeficiency virus strains. J Virol Methods 1988;19:191-196.
16. Sundqvist VA, Albert J, Ohlsson E, Hinkula J, Fenyö EM, and Wahren B: Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J Med Virol 1989;29:170-175.
17. Fenyö EM, Morfeldt-Månsson L, Chiodi F, Lind A, von Gegerfeldt A, Albert J, Olausson E, and Åsjö B: Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988;62:4414-4419.
18. Valentin A, Albert J, Fenyö EM, and Åsjö B: Dual tropism for macrophages and lymphocytes is a common feature of primary HIV-1 and HIV-2 isolates. J Virol 1994;68(10):684-6689.
19. Deng HK, Liu R, Ellmeier W, Choe S, Uunutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Liftman DR, and Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 1996;381:661-666.
20. Deng HK, Unutmaz D, KewalRamani VN, Littman DR: Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature (London) 1997;388:296-300.
21. Ayehunie S, Johansson B, Sönnerborg A, Zewdie D, Britton S, and Strannegård Ö: Sequence analysis of selected regions of the env (V3 loop and gp41) and gag (p7) reading frames of Ethiopian human immunodeficiency virus type 1 strains. Arch Virol 1993;128: 229-239.
22. Tabor S and Richardson CC: DNA sequence analysis with a modified bacteriophage T7DNA polymerase. Proc Natl Acad Sci USA 1987;84:4767-4771.
23. Johansson B, Sherefa K, and Sönnerborg A: Multiple enhancer motifs in the HIV type 1 strains from Ethiopia. AIDS Res Hum Retroviruses 1995;11:761-764.
24. Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, and Essex M: Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol 1997;71(11):8657-8665.
25. Duh EJ, Maury WJ, Folks TM, Fauci AS, and Rabson AB: Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc Natl Acad Sci USA 1989;86: 5974-5978.
26. Folks TM, Clouse KA, Justement A, Rabson A, Duh E, Kehrl JH, and Fauci AS: Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 1989;86:2365-2368.
27. Michihico S, Yamamoto N, Shinozaki F, Shimada K, Soma G, and Kobayashi N: Augmentation of in vitro HIV replication in peripheral blood mononuclear cells and of AIDS and ARC patients by tumor necrosis factor. Lancet 1989;i:1206-1207.
28. Mellors JW, Griffith BP, Ortiz MA, Landry ML, and Ryan JL: Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis 1991;163:78-82.
29. Matsuyama T, Kobayashi N, and Yamamoto N: Cytokines and HIV infection: Is AIDS a tumor necrosis factor disease? AIDS 1991;5: 1405-1417.
30. Lahdevirta J, Maury CP, Teppo AM, and Repo H: Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:289-291.
31. Ayehunie S, Sönnerborg A, Yemane Berhan T, Zewdie D-W, Britton S, and Strannegård Ö: Raised levels of tumor necrosis factor alpha and neopterin, but not interferon alpha, in serum of HIV-1 infected paitents from Ethiopia. Clin Exp Immunol 1993;91(1): 37-42.
32. de Wolf F, Hogervorst E, Goudsmit J, Fenyö EM, Rübsamen-Waigmann H, Holmes H, et al.: Syncytium-inducing (SI) and non-syncytium-inducing (NSI) capacity of human immunodeficiency virus type 1 (HIV-1) subtypes other than B: Phenotypic and genotypic characteristics. AIDS Res Hum Retroviruses 1994;10:1387-1400.